Min Fang
Direttore/Membro del Consiglio presso InSilico Medicine, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Aleksandrs Zhavoronkov | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 10 anni |
Yiwen Zhu | M | 60 | 15 anni | |
Feng Ren | M | 49 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 3 anni |
Ren Feng | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
Aleksandr Aliper | M | 34 |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 10 anni |
Steven Kenneth Galson | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
Jun Wang | F | 37 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 4 anni |
Jing Song Wang | M | 60 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 anni |
Roman Kyrychynskyi | M | 48 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 anni |
Denitsa Milanova | M | 39 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 anni |
Kan Chen | M | 42 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 3 anni |
Paul Stuart Auerbach | M | 72 |
Stanford University
| 19 anni |
Evelyne Bischof | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 5 anni |
Sujata Rao | M | 64 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 2 anni |
Jennifer Cochran | M | 52 |
Stanford University
| 19 anni |
Kan Chen | - | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
Fred M. Gibbons | M | 75 |
Stanford University
| 18 anni |
Garri Zmudze | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 8 anni |
Ming Zi Chen | M | 54 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 3 anni |
Stefan Heller | M | 58 |
Stanford University
| 19 anni |
Kwan Wai Leung | F | 43 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 anni |
Frank M. Longo | M | - |
Stanford University
| 18 anni |
Kwok Yin Lau | M | 39 | 3 anni | |
Evgeny Izumchenko | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 9 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Styrmir Sigurjonsson | M | 50 |
Stanford University
| 7 anni |
Aparna Sinha | M | - |
Stanford University
| - |
Hesaam Esfandyarpour | M | - |
Stanford University
| 5 anni |
Helmy Eltoukhy | M | 45 |
Stanford University
| 9 anni |
Ben Daniel | M | - |
Stanford University
| 1 anni |
Chase Beeler | M | - |
Stanford University
| 5 anni |
Zavain Dar | M | 35 |
Stanford University
| 6 anni |
Jung-il Choi | M | - |
Stanford University
| 6 anni |
Hugh Browne | M | - |
Stanford University
| 2 anni |
Iveshu Bhatia | M | - |
Stanford University
| 1 anni |
Geoffrey Woo | M | - |
Stanford University
| 4 anni |
Joel Dudley | M | - |
Stanford University
| 4 anni |
Adam Klotz | M | - |
Stanford University
| 10 anni |
Etosha Cave | M | - |
Stanford University
| 8 anni |
Kathy Hannun | F | - |
Stanford University
| 10 anni |
Eric Bahn | M | - |
Stanford University
| 5 anni |
Elaine Zelby | F | - |
Stanford University
| 5 anni |
Mada Seghete | F | - |
Stanford University
| 8 anni |
Greg Kress | M | - |
Stanford University
| 5 anni |
Haomiao Huang | M | - |
Stanford University
| 7 anni |
Neel Murthy | M | - |
Stanford University
| 6 anni |
Joseph Lau | M | - |
Stanford University
| - |
Wesley Lim | M | - |
Stanford University
| 4 anni |
Brain Banwoong Koo | M | - |
Stanford University
| 2 anni |
Nabeel Hasnain | M | - |
Stanford University
| 4 anni |
Erin Yang | F | - |
Stanford University
| 5 anni |
Forrest White | M | - |
Stanford University
| 5 anni |
Zheng Su | F | - |
Stanford University
| 4 anni |
Andreas Eckner | M | - |
Stanford University
| 4 anni |
John Melas-Kyriazi | M | - |
Stanford University
| 4 anni |
Charles H. House | M | 83 |
Stanford University
| - |
Samir Siddhanti | M | - |
Stanford University
| 5 anni |
Alex Gurevich | M | - |
Stanford University
| 5 anni |
Emily Melton | F | - |
Stanford University
| 10 anni |
Manu Kumar | M | - |
Stanford University
| 5 anni |
Elvina Mintarno | F | - |
Stanford University
| 4 anni |
Ali Jamal | M | - |
Stanford University
| 5 anni |
Andrew Gustin | M | - |
Stanford University
| 9 anni |
Elizabeth Weil | F | - |
Stanford University
| 6 anni |
Gee-Liek Yeo | M | - |
Stanford University
| 6 anni |
Rapp Alyssa | F | 45 |
Stanford University
| 2 anni |
Curtis Spencer | M | - |
Stanford University
| - |
Manu Lakkur | M | - |
Stanford University
| 5 anni |
Dmitry Pushkarev | M | - |
Stanford University
| 5 anni |
Mike Rothenberg | M | - |
Stanford University
| 5 anni |
Elizabeth Xie | M | - |
Stanford University
| 6 anni |
Guillaume Horel | M | - |
Stanford University
| 4 anni |
Alex W. Bergman | M | - |
Stanford University
| 2 anni |
Satyan Gajwani | M | 39 |
Stanford University
| 4 anni |
Karen Martell | F | - |
Stanford University
| 4 anni |
Stephen D. Klein | M | - |
Stanford University
| 5 anni |
John Komkov | M | - |
Stanford University
| 10 anni |
James P. McGillicuddy | M | - |
Stanford University
| 5 anni |
Steve Abraham | M | - |
Stanford University
| 5 anni |
Michael Paulus | M | - |
Stanford University
| 5 anni |
Jason Min | M | - |
Stanford University
| 6 anni |
Kunal Ghosh | M | - |
Stanford University
| 5 anni |
Nick Noone | M | - |
Stanford University
| 4 anni |
Lyndsay Erickson | F | - |
Stanford University
| 5 anni |
Curtis McKee | M | - |
Stanford University
| 5 anni |
Li Lu | M | - |
Stanford University
| 7 anni |
Steve Levin | M | - |
Stanford University
| 2 anni |
Kent Kristin | F | - |
Stanford University
| 4 anni |
Ha Anthony | M | - |
Stanford University
| 5 anni |
Yun Yau Li | M | 45 |
Stanford University
| 3 anni |
Fiona O'Donnell McCarthy | F | - |
Stanford University
| 4 anni |
Tobias Oriwol | M | - |
Stanford University
| 4 anni |
Julie H. Park | F | - |
Stanford University
| 4 anni |
Yu Chen | M | 43 |
Stanford University
| 1 anni |
Scott Hofmeister | M | - |
Stanford University
| 4 anni |
Omri Amirav-Drory | M | - |
Stanford University
| 4 anni |
Soo Huan Xi | M | - |
Stanford University
| 1 anni |
Austin Yount | M | - |
Stanford University
| 3 anni |
Vivek Patel | M | 45 |
Stanford University
| 1 anni |
Sara Thomas Deshpande | F | - |
Stanford University
| 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 89 | 89.90% |
Hong Kong | 11 | 11.11% |
Cina | 2 | 2.02% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Min Fang
- Contatti personali